Palo Alto Investors as of Dec. 31, 2012
Portfolio Holdings for Palo Alto Investors
Palo Alto Investors holds 33 positions in its portfolio as reported in the December 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Onyx Pharmaceuticals | 17.2 | $146M | 1.9M | 75.53 | |
Cyberonics | 12.0 | $102M | 1.9M | 52.53 | |
ViroPharma Incorporated | 10.2 | $87M | 3.8M | 22.76 | |
United Therapeutics Corporation (UTHR) | 7.6 | $65M | 1.2M | 53.42 | |
Questcor Pharmaceuticals | 7.0 | $60M | 2.2M | 26.72 | |
BioMarin Pharmaceutical (BMRN) | 5.4 | $46M | 929k | 49.20 | |
Auxilium Pharmaceuticals | 5.2 | $45M | 2.4M | 18.54 | |
Cubist Pharmaceuticals | 4.1 | $35M | 833k | 42.05 | |
Sequenom | 4.1 | $35M | 7.4M | 4.71 | |
ArthroCare Corporation | 3.5 | $30M | 871k | 34.59 | |
AMAG Pharmaceuticals | 3.1 | $27M | 1.8M | 14.71 | |
Abiomed | 2.8 | $24M | 1.8M | 13.44 | |
Momenta Pharmaceuticals | 2.6 | $22M | 1.9M | 11.79 | |
STAAR Surgical Company (STAA) | 2.5 | $22M | 3.5M | 6.10 | |
InterMune | 2.0 | $17M | 1.8M | 9.69 | |
Qlt | 1.9 | $17M | 2.1M | 7.86 | |
Amicus Therapeutics (FOLD) | 1.5 | $13M | 4.8M | 2.68 | |
Savient Pharmaceuticals | 1.4 | $12M | 11M | 1.05 | |
Rigel Pharmaceuticals | 1.3 | $11M | 1.7M | 6.50 | |
Conceptus | 1.1 | $9.4M | 449k | 21.00 | |
Alimera Sciences | 0.7 | $5.7M | 3.6M | 1.57 | |
Aegerion Pharmaceuticals | 0.6 | $5.3M | 210k | 25.38 | |
Vanda Pharmaceuticals (VNDA) | 0.6 | $5.3M | 1.4M | 3.70 | |
NuVasive | 0.3 | $2.6M | 170k | 15.46 | |
Dendreon Corporation | 0.3 | $2.2M | 413k | 5.29 | |
Northern Oil & Gas | 0.2 | $1.9M | 112k | 16.82 | |
Insmed (INSM) | 0.2 | $1.8M | 266k | 6.69 | |
Hyperion Therapeutics | 0.2 | $1.7M | 150k | 11.28 | |
Sonde Resources | 0.1 | $1.1M | 678k | 1.64 | |
Cytokinetics | 0.1 | $1.0M | 1.6M | 0.66 | |
pSivida | 0.1 | $985k | 814k | 1.21 | |
NxStage Medical | 0.1 | $496k | 44k | 11.24 | |
Theratechnologies | 0.0 | $112k | 351k | 0.32 |